UNIFI INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data UNIFI INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	647	679	709	607	668	816	624	582	571	531
Cost of revenue	553	592	642	567	574	735	609	566	563	501
Gross profit	94.2	86.4	66.3	39	93.5	80.5	14.2	16.6	8.42	30.5
Research and development	7.18	7.79	12.4	11.3	11.5	12.1	10.9	9.6	8.75	7.71
Selling, general and administrative	50.8	56.1	52.7	43.8	51.3	52.5	47.3	46.6	49	44.7
Operating income	43.8	28.8	11	-8.82	38.6	28.6	-40.9	-37.4	-9.52	-14.6
Interest expense	3.58	4.94	5.41	4.78	3.32	3.09	7.58	9.86	9.52	6.81
Interest income	0.52	0.56	0.63	0.72	0.6	1.52	2.11	2.14	0.89	1.69
Pre-tax income	43.3	30.2	10	-56.3	46.3	26.8	-45.4	-45.5	-18.6	-20
Income tax	10.9	-1.49	7.56	0.97	17.3	11.7	0.9	1.86	1.72	4.53
Net income to minority interests	-0.5
Net income	32.9	31.7	2.46	-57.2	29.1	15.2	-46.3	-47.4	-20.3	-24.6
EBITDA	64.1	51.4	34	14.8	64.1	54.8	-13.7	-9.75	15.8	9.4
EPS, basic	1.81	1.73	0.13	-3.10	1.57	0.82	-2.57	-2.61	-1.11	-1.33
EPS, diluted	1.78	1.70	0.13	-3.10	1.54	0.80	-2.57	-2.61	-1.11	-1.33
Shares, basic (weighted)	18.1	18.3	18.4	18.5	18.5	18.4	18	18.2	18.3	18.5
Shares, diluted (weighted)	18.4	18.6	18.7	18.5	18.9	18.9	18	18.2	18.3	18.5

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	35.4	44.9	22.2	75.3	78.3	53.3	47	26.8	22.7	25.1
Receivables	79.8	85	86.2	48.6	78.7	97.6	77.1	76.6	73.2	75.3
Inventory	111	126	134	110	141	173	151	131	123	101
Other current assets	6.47	6.53	16.4	11.8	12.4	19	12.3	11.6	9.22	7.74
Total current assets	244	274	266	254	329	352	294	249	236	211
Property, plant and equipment	203	206	207	204	202	216	219	194	173	158
Lease right-of-use assets				8.94	8.77	8.83	7.79	8.25	7.88	6.53
Intangible assets	2.16	2.99	2.17	1.41	3.98	2.5	1.21	0.68	0.57	0.47
Other non-current assets	0.61	3.08	0.67	4.13	14.6	8.79	14.5	13	4.9	4.81
Total assets	572	602	592	474	555	589	539	469	427	386
Accounts payable	41.5	49	41.8	25.6	54.3	73.5	44.5	43.6	37.5	31.2
Accrued liabilities	16.1	17.7	16.8	13.7	10.2	9.41	6.98	7.14	6.82	6.41
Deferred revenue			0.52	1.28	2.69	1.69	1.44	1.5	1.24	1.17
Short-term debt	10	10	15.5	13.6	16	11.7	12	12.3	12.2	12.4
Total current liabilities	76.1	85	74.7	55	105	109	72	76.6	70.9	63.6
Long-term debt	111	114	112	84.6	70.3	102	129	118	95.7	80
Lease liabilities				7.25	7.03	6.74	6.15	6.12	5.61	4.46
Other non-current liabilities	11.8	5.34	6.19	8.61	7.47	4.45	5.1	3.51	3.89	5.2
Total liabilities	211	212	199	158	197	227	215	206	177	154
Total debt	129	131	128	98.9	0.88	0.73	1.63	0	108	92.4
Paid-in capital	51.9	56.7	59.6	62.4	65.2	66.1	68.9	71	74.1	77.2
Retained earnings	340	372	375	316	345	353	307	259	239	214
Other comprehensive income	-32.9	-40.5	-43.2	-63.8	-53.4	-59.6	-53.9	-68.8	-65.5	-61.3
Shareholders' equity	361	390	393
Total equity	361	390	393	316	358	361	324	263	249	232
Total liabilities and equity	572	602	592	474	555	589	539	469	427	386
Shares outstanding	18.2	18.4	18.5	18.4	18.5	18	18.1	18.3	18.4	18.6

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	32.4	31.7	2.46	-57.2	29.1	15.2	-46.3	-47.4	-20.3	-24.6
Depreciation and amortization	20.4	22.6	23	23.7	25.5	26.2	27.2	27.7	25.3	24.1
Stock-based compensation	2.18	4.93	2.65	3.51	3.06	3.18	2.71	2.02	3.26	3.49
Deferred income tax	6.89	-5.8	0.42	-4.01	5.09	-3.12	-2.79	-3.54	-0.68	0.24
Change in receivables	1.59	-7.53	-2.92	30	-40.1	-13.5	23.1	1.99	4.56	0.49
Change in inventory	-8.52	-18.2	-15.8	15.8	-28.1	-34.7	24.4	13.9	9.59	24.4
Change in payables	-1.21	8.67	-5.81	-17.3
Cash from operations	46.1	37.3	7.28	52.7	36.7	0.38	4.74	2.09	-21.3	26.5
Capital expenditures	-33.2	-25	-24.9	-18.5	-21.2	-39.6	-36.4	-11.2	-10.5	-5
Cash from investing	-33.4	-26.9	-24.9	41.6	-24.6	-41.7	-36.2	-10.7	41.1	-4.45
Stock issued	2.79	0.22	0.48	0.03
Dividends paid	0	0	0	0	0	0	0	0	0	0
Cash from financing	6.5	1.3	-4.63	-37.9	-12.9	18	25.9	-10.6	-24.4	-19.9
Exchange rate effect	-0.41	-2.3	-0.38	-3.34	3.8	-1.57
Net change in cash	18.8	9.47	-22.7	53	2.99	-25	-6.33	-20.2	-4.14	2.41
Free cash flow	12.9	12.3	-17.6	34.2	15.5	-39.3	-31.7	-9.1	-31.8	21.5
Interest paid	3.28	4.46	5.34	4.68	3.16	2.92	5.82	9.52	9.61	6.97
Income taxes paid	8.12	9.96	2.62	6.13	8.24	13	6.07	5.76	3.49	1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 27, 2026; growth uses fiscal years. Valuation uses the share price of $6.31 on November 9, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	7.6%	Gross profit / revenue.
Operating margin	-1.0%	Operating income / revenue.
EBITDA margin	3.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-1.9%	Pre-tax income / revenue.
Net margin	-2.9%	Net income / revenue.
FCF margin	6.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.5%	Cash from operations / revenue.
Return on assets (ROA)	-3.9%	Net income / average total assets.
SG&A / revenue	8.4%	Selling, general and administrative expense / revenue.
Capex / revenue	0.8%	Capital expenditures / revenue.
D&A / revenue	4.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-7.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-5.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-4.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	261.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	28.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-20.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-40.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y	-31.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y	77.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-6.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	6.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-9.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-10.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-7.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.22x	Current assets / current liabilities.
Quick ratio	1.43x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.38x	(Cash + short-term investments) / current liabilities.
Debt / assets	23.4%	Total debt / total assets.
Liabilities / assets	40.5%	Total liabilities / total assets.
Net debt	$64.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.45x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	-0.81x	Operating income / interest expense.
Working capital	$150.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	0.1%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.35x	Revenue / average total assets.
Fixed asset turnover	3.41x	Revenue / average property, plant and equipment.
Inventory turnover	4.43x	Cost of revenue / average inventory.
Days inventory	82 days	365 x average inventory / cost of revenue.
Receivables turnover	7.34x	Revenue / average receivables.
Days sales outstanding	50 days	365 x average receivables / revenue.
Days payables	28 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	104 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	10.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.82	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$28.17	Revenue / diluted weighted shares.
FCF per share	$1.88	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.11	Cash from operations / diluted weighted shares.
Cash per share	$1.40	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$117.3M	Share price x shares outstanding.
Enterprise value	$182.1M	Market cap + total debt - cash - short-term investments.
P/S	0.22x	Market cap / revenue.
P/FCF	3.35x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	3.00x	Market cap / cash from operations, when positive.
EV/Sales	0.35x	Enterprise value / revenue.
EV/EBITDA	9.69x	Enterprise value / EBITDA, when both are positive.
EV/FCF	5.21x	Enterprise value / free cash flow, when both are positive.
FCF yield	29.8%	Free cash flow / market cap.
Earnings yield	-13.0%	Net income / market cap (the inverse of P/E).

What was UNIFI INC's revenue in fiscal 2026?

UNIFI INC reported revenue of $531.3M for fiscal 2026, 7% lower than the year before.

Was UNIFI INC profitable in fiscal 2026?

No. It reported a net loss of $24.6M.

How much free cash flow did UNIFI INC generate in fiscal 2026?

Cash from operations of $26.5M minus capital expenditures of $5.0M left free cash flow of $21.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to UNIFI INC